Literature DB >> 23924496

Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma: a cross-sectional case-control study from Chinese patients with HBV infection.

Chun Gao1, Long Fang, Hong-Chuan Zhao, Jing-Tao Li, Shu-Kun Yao.   

Abstract

BACKGROUND: Diabetes mellitus (DM) is regarded as a new risk factor for hepatocellular carcinoma (HCC), but few studies have focused on the potential role of DM in the progression of cirrhosis to HCC as well as in patients with simple HBV infection.
METHODS: A cohort of 1028 patients, treated at our hospital and with a hospital discharge diagnosis of HCC and/or cirrhosis, was screened. Among them, 558 were diagnosed with chronic HBV infection and 370 were analyzed statistically according to the diagnostic, inclusion and exclusion criteria. The demographic, clinical, metabolic, virological, biochemical, radiological and pathological features were analyzed and the multivariate logistic regression model was used to determine the potential role of DM.
RESULTS: In 248 cirrhotic patients, 76 were diabetic and their mean duration of DM was 4.6 years. In 122 HCC patients with cirrhosis, 25 were diabetic and their mean duration of DM was 4.4 years. Univariate analysis showed that compared with cirrhotic patients, the HCC patients had a higher percentage in males (P=0.001), a lower percentage in DM patients (P=0.039), a higher percentage in cigarette smokers (P=0.005), a higher percentage in patients with AFP>400 ng/mL (P<0.001), higher values of white blood cells (P<0.001), hemoglobin (P<0.001) and platelet (P<0.001), increased levels of ALT (P<0.001) and GGT (P<0.001), higher total bilirubin (P=0.018) and albumin levels (P<0.001), and a lower international normalized ratio (P<0.001). Multivariate logistic regression analysis showed that DM was an independent associated factor for HCC [odds ratio (OR)=0.376; 95% CI, 0.175-0.807; P=0.012]. Even after the HCC patients were restricted to those with decompensated cirrhosis and compared with decompensated cirrhotic patients, the similar result was observed (OR=0.192; 95% CI, 0.054-0.679; P=0.010).
CONCLUSIONS: DM is an independent factor in the progression of cirrhosis to HCC, but the role may be contrary to our current viewpoint. To clarify the causal relationship of DM and HCC, prospective and experimental studies are required.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23924496     DOI: 10.1016/s1499-3872(13)60060-0

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  12 in total

1.  Editorial: diabetes and its association with hepatocellular carcinoma in chronic hepatitis B.

Authors:  M Konerman; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2015-07       Impact factor: 8.171

2.  A single nucleotide polymorphism CTSB rs12898 is associated with primary hepatic cancer in a Chinese population.

Authors:  Minghua Cui; Quanzhu Chen; Chaojun He; Nan Wang; Yong Yu; Ziyang Sun; Zhenhua Lin; Hesong Cui; Shengyu Jin; Jae Yong Park; Guang Jin; Shin Yup Lee; Qingsong Cui
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

3.  25-HC promotes hepatocellular carcinoma metastasis through up-regulation of TLR4 dependent FABP4.

Authors:  Saisai Wang; Yuanyuan Yao; Xiao Wang; Gang Zheng; Wei Ouyang; Wenbin Chen
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

4.  Significance and prognostic value of increased serum direct bilirubin level for lymph node metastasis in Chinese rectal cancer patients.

Authors:  Chun Gao; Long Fang; Jing-Tao Li; Hong-Chuan Zhao
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

Review 5.  Molecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinoma.

Authors:  Chun Gao
Journal:  World J Hepatol       Date:  2016-09-28

Review 6.  Hepatocellular carcinoma: a review.

Authors:  Julius Balogh; David Victor; Emad H Asham; Sherilyn Gordon Burroughs; Maha Boktour; Ashish Saharia; Xian Li; R Mark Ghobrial; Howard P Monsour
Journal:  J Hepatocell Carcinoma       Date:  2016-10-05

7.  Association Between Hepatocellular Carcinoma and Type 2 Diabetes Mellitus in Chinese Hepatitis B Virus Cirrhosis Patients: A Case-Control Study.

Authors:  Huixian Han; Han Deng; Tao Han; Haitao Zhao; Feifei Hou; Xingshun Qi
Journal:  Med Sci Monit       Date:  2017-07-09

8.  Increased Level of Systolic Blood Pressure in Hepatocellular Carcinoma Patients with Diabetes Mellitus.

Authors:  Wei-Shuo Zhang; Xiao-Ou Li; Hui Zhang; Chun Gao; Long Fang; Hua-Yuan Yang
Journal:  Diabetes Metab Syndr Obes       Date:  2020-06-15       Impact factor: 3.168

Review 9.  Diabetes Mellitus and Risk of Hepatocellular Carcinoma.

Authors:  Xu Li; Xiaocong Wang; Pujun Gao
Journal:  Biomed Res Int       Date:  2017-12-12       Impact factor: 3.411

10.  Diabetes Mellitus is a Risk Factor for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection in China.

Authors:  Xu Li; Hongqin Xu; Pujun Gao
Journal:  Med Sci Monit       Date:  2018-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.